Issue navigation
Volume 63, Issue 1, January 2024
EDITORIALS
Are all entheses the same?
Rheumatology, Volume 63, Issue 1, January 2024, Pages 1–2, https://doi.org/10.1093/rheumatology/kead288
Accelerated atherosclerosis in systemic lupus erythematosus: don’t forget the devil we know!
Rheumatology, Volume 63, Issue 1, January 2024, Pages 3–5, https://doi.org/10.1093/rheumatology/kead329
Lights and shadows on the efficacy of tocilizumab monotherapy in large vessel giant cell arteritis
Rheumatology, Volume 63, Issue 1, January 2024, Pages 6–7, https://doi.org/10.1093/rheumatology/kead358
SYSTEMATIC REVIEWS AND META ANALYSIS
Neuropsychiatric lupus in late- and early-onset systemic lupus erythematosus patients: a systematic review and meta-analysis
Rheumatology, Volume 63, Issue 1, January 2024, Pages 8–15, https://doi.org/10.1093/rheumatology/kead297
Body composition parameters in systemic sclerosis—a systematic review and meta-analysis
Rheumatology, Volume 63, Issue 1, January 2024, Pages 16–25, https://doi.org/10.1093/rheumatology/kead418
REVIEWS
Calprotectin: two sides of the same coin
Rheumatology, Volume 63, Issue 1, January 2024, Pages 26–33, https://doi.org/10.1093/rheumatology/kead405
CLINICAL SCIENCE
Treatment decisions in axial spondyloarthritis daily clinical practice are more than treat-to-target
Rheumatology, Volume 63, Issue 1, January 2024, Pages 34–40, https://doi.org/10.1093/rheumatology/kead155
Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCEED study
Rheumatology, Volume 63, Issue 1, January 2024, Pages 41–49, https://doi.org/10.1093/rheumatology/kead181
The impact of traditional cardiovascular risk factor control on 7-year follow-up atherosclerosis progression in systemic lupus erythematosus
Rheumatology, Volume 63, Issue 1, January 2024, Pages 50–57, https://doi.org/10.1093/rheumatology/kead184
Development of a computed tomography calcium scoring technique for assessing calcinosis distribution, pattern and burden in dermatomyositis
Rheumatology, Volume 63, Issue 1, January 2024, Pages 58–63, https://doi.org/10.1093/rheumatology/kead256
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study
Rheumatology, Volume 63, Issue 1, January 2024, Pages 64–71, https://doi.org/10.1093/rheumatology/kead215
Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist’s judgement?
Rheumatology, Volume 63, Issue 1, January 2024, Pages 72–78, https://doi.org/10.1093/rheumatology/kead159
Sirolimus for the treatment of patients with refractory connective tissue disease-related thrombocytopenia: a pilot study
Rheumatology, Volume 63, Issue 1, January 2024, Pages 79–84, https://doi.org/10.1093/rheumatology/kead160
Magnetic resonance imaging characteristics in patients with psoriatic arthritis and axial manifestations from the MAXIMISE cohort
Rheumatology, Volume 63, Issue 1, January 2024, Pages 85–92, https://doi.org/10.1093/rheumatology/kead162
Cancer risk in patients with rheumatoid arthritis treated with janus kinase inhibitors: a nationwide Danish register-based cohort study
Rheumatology, Volume 63, Issue 1, January 2024, Pages 93–102, https://doi.org/10.1093/rheumatology/kead163
Prognostic value of automated assessment of interstitial lung disease on CT in systemic sclerosis
Rheumatology, Volume 63, Issue 1, January 2024, Pages 103–110, https://doi.org/10.1093/rheumatology/kead164
Semi-quantitative thigh magnetic resonance imaging scores in assessing disease activity and determining long-term clinical outcome in idiopathic inflammatory myopathies: a causal mediation analysis
Rheumatology, Volume 63, Issue 1, January 2024, Pages 111–118, https://doi.org/10.1093/rheumatology/kead174
Implications of the accuracy of diagnostic algorithms for systemic lupus on our understanding of racial disparities in pregnancy outcomes
Rheumatology, Volume 63, Issue 1, January 2024, Pages 119–126, https://doi.org/10.1093/rheumatology/kead178
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys
Rheumatology, Volume 63, Issue 1, January 2024, Pages 127–139, https://doi.org/10.1093/rheumatology/kead180
Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis
Rheumatology, Volume 63, Issue 1, January 2024, Pages 140–148, https://doi.org/10.1093/rheumatology/kead183
Paranasal sinus occupancy assessed from magnetic resonance images—associations with clinical indicators in patients with systemic lupus erythematosus
Rheumatology, Volume 63, Issue 1, January 2024, Pages 149–157, https://doi.org/10.1093/rheumatology/kead185
Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica
Rheumatology, Volume 63, Issue 1, January 2024, Pages 158–164, https://doi.org/10.1093/rheumatology/kead189
Ultraprocessed food consumption, genetic predisposition, and the risk of gout: the UK Biobank study
Rheumatology, Volume 63, Issue 1, January 2024, Pages 165–173, https://doi.org/10.1093/rheumatology/kead196
Association of the AAV-PRO questionnaire with established outcome measures in AAV
Rheumatology, Volume 63, Issue 1, January 2024, Pages 174–180, https://doi.org/10.1093/rheumatology/kead199
Validation of a patient-reported outcome measure for giant cell arteritis
Rheumatology, Volume 63, Issue 1, January 2024, Pages 181–189, https://doi.org/10.1093/rheumatology/kead201
The association between sonographic enthesitis with sonographic synovitis and tenosynovitis in psoriatic arthritis patients
Rheumatology, Volume 63, Issue 1, January 2024, Pages 190–197, https://doi.org/10.1093/rheumatology/kead202
BASIC SCIENCE
Kv1.3 blockade by ShK186 modulates CD4+ effector memory T-cell activity of patients with granulomatosis with polyangiitis
Rheumatology, Volume 63, Issue 1, January 2024, Pages 198–208, https://doi.org/10.1093/rheumatology/kead192
Effect of type I interferon on engineered pediatric skeletal muscle: a promising model for juvenile dermatomyositis
Rheumatology, Volume 63, Issue 1, January 2024, Pages 209–217, https://doi.org/10.1093/rheumatology/kead186
Differences in transcriptional changes in psoriasis and psoriatic arthritis skin with immunoglobulin gene enrichment in psoriatic arthritis
Rheumatology, Volume 63, Issue 1, January 2024, Pages 218–225, https://doi.org/10.1093/rheumatology/kead195
The differential crosstalk of the skin–gut microbiome axis as a new emerging actor in systemic sclerosis
Rheumatology, Volume 63, Issue 1, January 2024, Pages 226–234, https://doi.org/10.1093/rheumatology/kead208
Tumour-associated antigens in systemic lupus erythematosus: association with clinical manifestations and serological indicators
Rheumatology, Volume 63, Issue 1, January 2024, Pages 235–241, https://doi.org/10.1093/rheumatology/kead224
An immunomodulatory antibody–drug conjugate targeting BDCA2 strongly suppresses plasmacytoid dendritic cell function and glucocorticoid responsive genes
Rheumatology, Volume 63, Issue 1, January 2024, Pages 242–250, https://doi.org/10.1093/rheumatology/kead219
Serum level of galectin-9 as a potential biomarker for high risk of malignancy in dermatomyositis
Rheumatology, Volume 63, Issue 1, January 2024, Pages 251–258, https://doi.org/10.1093/rheumatology/kead222
CORRECTION
Correction to: Treatment decisions in axial spondyloarthritis daily clinical practice are more than treat-to-target
Rheumatology, Volume 63, Issue 1, January 2024, Page 259, https://doi.org/10.1093/rheumatology/kead206
LETTERS TO THE EDITOR
OTHER
Hypogammaglobulinemia in rheumatoid arthritis patients on rituximab: prevalence and risk factors
Rheumatology, Volume 63, Issue 1, January 2024, Pages e1–e2, https://doi.org/10.1093/rheumatology/kead326
CASE REPORTS
Raynaud’s phenomenon and digital ischaemia induced by ixekizumab
Rheumatology, Volume 63, Issue 1, January 2024, Pages e3–e5, https://doi.org/10.1093/rheumatology/kead270
Impact of guselkumab on three cases of SSc accompanying psoriasis
Rheumatology, Volume 63, Issue 1, January 2024, Pages e6–e8, https://doi.org/10.1093/rheumatology/kead287
First reported case of pulmonary arteritis in patients with relapsing polychondritis
Rheumatology, Volume 63, Issue 1, January 2024, Pages e9–e11, https://doi.org/10.1093/rheumatology/kead300
Rescue therapy of antisynthetase syndrome with CD19-targeted CAR-T cells after failure of several B-cell depleting antibodies
Rheumatology, Volume 63, Issue 1, January 2024, Pages e12–e14, https://doi.org/10.1093/rheumatology/kead330
Switching from prednisolone to dexamethasone in difficult-to-treat rheumatoid arthritis
Rheumatology, Volume 63, Issue 1, January 2024, Pages e15–e16, https://doi.org/10.1093/rheumatology/kead334
Rapid handheld measurements of skin and subcutaneous tissue stiffness in systemic sclerosis
Rheumatology, Volume 63, Issue 1, January 2024, Pages e17–e19, https://doi.org/10.1093/rheumatology/kead355
CLINICAL VIGNETTES
Infection after vertebroplasty in an 83-year-old male
Rheumatology, Volume 63, Issue 1, January 2024, Pages e20–e21, https://doi.org/10.1093/rheumatology/kead311
Sarcoidosis presented as nodular myopathy
Rheumatology, Volume 63, Issue 1, January 2024, Pages e22–e23, https://doi.org/10.1093/rheumatology/kead327
Malar rash in a febrile infant: is this Kawasaki disease?
Rheumatology, Volume 63, Issue 1, January 2024, Pages e24–e25, https://doi.org/10.1093/rheumatology/kead338
When spondyloarthritis presents as a complex and multi-system disease
Rheumatology, Volume 63, Issue 1, January 2024, Pages e26–e27, https://doi.org/10.1093/rheumatology/kead339
Arthritis mutilans in polyarticular JIA
Rheumatology, Volume 63, Issue 1, January 2024, Page e28, https://doi.org/10.1093/rheumatology/kead340
